In Germany, the forecasted use of antidepressant medicine is projected to increase steadily from 2024 to 2028. In 2024, the use rate is anticipated to be at 68.8 units, rising to 70.2 units in 2025, 71.5 units in 2026, 72.6 units in 2027, and finally reaching 73.7 units by 2028, expressed as defined daily dosages per thousand persons per day. These values illustrate a consistent upward trend over the forecast period.
The year-on-year percentage variation reveals a gradual increase each year, indicating an expanding reliance on antidepressant medication. From 2023 to 2024, there was a notable increase which continues at a steady rate, demonstrating a 2.03% rise from 2024 to 2025, a 1.85% increase from 2025 to 2026, a 1.54% rise from 2026 to 2027, and a 1.52% growth from 2027 to 2028. The Compounded Annual Growth Rate (CAGR) over the five-year span is circa 1.74%, reflecting moderate, consistent growth.
Future trends to watch for include the integration of new and more effective antidepressant therapies, greater societal acceptance of mental health treatment, and potential policy shifts that could affect prescription rates. Additionally, any major societal, economic, or healthcare system changes may significantly influence these projections.
